NeuroOne Medical Technologies Discusses Platform Advancements and Growth Plans for Neurological Devices

jueves, 12 de marzo de 2026, 4:04 pm ET1 min de lectura
NMTC--

NeuroOne Medical Technologies Corporation (NMTC) discussed platform technology advancements and growth plans for neurological device applications. CEO Dave Rosa highlighted the company's goal of delivering a thin film electrode platform technology offering multiple functions using the same device for various neurological applications. The company aims to expand its product portfolio and increase revenue in 2026.

NeuroOne Medical Technologies Discusses Platform Advancements and Growth Plans for Neurological Devices

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios